Discover 2,356 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,356
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
for
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8,
Location: Irvine CA, Newport Beach CA, Corona CA,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07288034
Phase 2, Recruiting
A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Orange CA, Los Angeles CA, Boise ID, Austin TX,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase 3, Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
for
AMI Cardiogenic Shock
Location: Orange CA, Torrance CA, Albuquerque NM, Portland OR,
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT06964685
Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
for
Carcinoma, Hepatocellular, Hepatocellular Cancer,
Location: Irvine CA, Orange CA, Los Angeles CA, Pasadena CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227012
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Lake Forest CA, Spring Valley CA, Rancho Cucamonga CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07112872
Phase 2, Recruiting
New
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
for
SARS-CoV-2
Location: Ontario CA, South Ogden UT, Brownsville TX, Beaumont TX,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0 - 11
Code: NCT07808697
Phase 2, Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors